The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Expert perspective: Inside Accelerator™ Drug Development, 360° CDMO and CRO solution
Meet Thermo Fisher Scientific’s subject matter experts as they share insights, experience, and guidance to help biotech and pharma companies navigate every stage of drug development.
As drug development programs move from discovery through clinical trials, every phase introduces new scientific, operational, and regulatory challenges. Traditionally, biotechnology and pharmaceutical companies have relied on multiple third-party vendors throughout this journey, which can create fragmented processes, communication gaps, and costly delays.
Accelerator™ Drug Development simplifies that complexity by bringing together connected expertise, shared governance, and seamless execution across the development lifecycle.
Through an end-to-end approach, Thermo Fisher Scientific serves as a single strategic partner—integrating drug substance and drug product development and manufacturing, analytical services, clinical supply, clinical operations, and project management. With one coordinated team aligning strategies and timelines, your team can stay focused on advancing the science.
What integrated services and solutions does Accelerator™ Drug Development include?
- Early development
- Drug product manufacturing
- Clinical trial strategy
- Clinical supply
- Clinical trial execution
- Enabling technologies
- Integrated project management
Watch our new video to see how Accelerator™ Drug Development seamlessly brings together Thermo Fisher Scientific's integrated CDMO and CRO capabilities to help biotech and pharma companies save time and money, reduce risk, and expedite the path to market.
Helpful resources
Video
Prioritizing scalability early on is key to successful drug development: Expert insight series
Go inside Accelerator™ Drug Development to discover why building a robust, scalable strategy from the early phases of biotech and pharma development programs is essential to long-term success.
Video
How a stage-gated approach improves drug product manufacturing: Expert insight series
Go inside Accelerator™ Drug Development to discover what sets a program up for manufacturing success—and why a rigorous, stage-gated approach that connects key stakeholders is essential.
Video
Why a well-planned supply strategy is essential for clinical success: Expert insight series
Go inside Accelerator™ Drug Development to understand the importance of a well-planned supply strategy—and how early cross-team coordination can help avoid delays in clinical development.
Video
Successful clinical trial execution begins with an end-to-end strategy: Expert insight series
Go inside Accelerator™ Drug Development to discover why successful clinical trials require an end-to-end strategy that aligns clinical, regulatory, and supply activities from the start of study planning.
Video
The role of enabling technologies in transforming drug development: Expert insight series
Go inside Accelerator™ Drug Development to discover how enabling technologies such as AI-powered analytics are transforming drug development by connecting teams, data, and workflows.
Video
How integration helps overcome common outsourcing inefficiencies: Expert insight series
Go inside Accelerator™ Drug Development to discover how an integrated outsourcing model helps overcome inefficiencies caused by fragmentation, enabling development teams to move faster.